PT Royal Prima Tbk (ISX:PRIM) 6-Month Price Index: 1.58 (As of Sep. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:PRIM PT Royal Prima Tbk ISX:PRIM
67 GF Score
Price Rp117.00
GF Value Rp78.06
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is PT Royal Prima Tbk 6-Month Price Index?

PT Royal Prima Tbk ISX:PRIM 67 6-Month Price Index is 1.58 as of Sep. 05, 2026. GuruFocus rates ISX:PRIM with a GF Score™ of 67/100 and a GF Value™ of Rp78.06 (Significantly Overvalued). The stock has 6 warning signs investors should review.

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2026-09-05), PT Royal Prima Tbk's 6-Month Price Index is 1.58.

PT Royal Prima Tbk  (ISX:PRIM) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.

PT Royal Prima Tbk 6-Month Price Index Related Terms

ISX:PRIM vs HCA, THC, EHC: 6-Month Price Index Comparison

For the Medical Care Facilities subindustry, PT Royal Prima Tbk's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ISX:PRIM
67GF Score
PT Royal Prima Tbk ISX:PRIM
6-Month Price Index is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Royal Prima Tbk  (ISX:PRIM) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index=Current Share Price / Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 6-Month Price Index →
What does a 6-Month Price Index of 1.58 mean?
PT Royal Prima Tbk (ISX:PRIM) has a 6-Month Price Index of 1.58 as of Sep. 05, 2026. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on PT Royal Prima Tbk and its competitors.
Is PT Royal Prima Tbk's 6-Month Price Index too high?
PT Royal Prima Tbk's current 6-Month Price Index is 1.58. Overall, PT Royal Prima Tbk has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Royal Prima Tbk's 6-Month Price Index compare to HCA and THC?
PT Royal Prima Tbk's 6-Month Price Index of 1.58 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-Month Price Index for a Healthcare Providers & Services company?
A good 6-Month Price Index depends on the Healthcare Providers & Services industry context. However, 6-Month Price Index should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-Month Price Index mean?
A high 6-Month Price Index can signal that a stock is expensive relative to its fundamentals. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on PT Royal Prima Tbk and its competitors. PT Royal Prima Tbk's current 6-Month Price Index is 1.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Royal Prima Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Royal Prima Tbk (ISX:PRIM) is currently considered Significantly Overvalued. The stock's GF Value™ is Rp78.06, compared to a current price of Rp117.00 — trading 49.9% above its estimated fair value. The current 6-Month Price Index is 1.58. PT Royal Prima Tbk's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-Month Price Index calculated?
6-Month Price Index is calculated from a company's financial statements. For PT Royal Prima Tbk (ISX:PRIM), the current 6-Month Price Index is 1.58 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Royal Prima Tbk (ISX:PRIM) Overvalued in 2026?

Based on GuruFocus' analysis, PT Royal Prima Tbk stock appears to be overvalued. The current stock price of Rp117.00 is trading 49.9% above its estimated GF Value™ of Rp78.06. GuruFocus considers PT Royal Prima Tbk to be Significantly Overvalued.

Key valuation signals for ISX:PRIM:

  • 6-Month Price Index: 1.58
  • GF Value™: Rp78.06 vs. price of Rp117.00 (49.9% above fair value)
  • GF Score™: 67/100 with 6 warning signs

No single metric tells the full story. See the ISX:PRIM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Royal Prima Tbk Business Description

Address Jalan. Ayahanda No. 68A, Sumatera Utara, Medan, IDN, 20118
PT Royal Prima Tbk is engaged in health services which consist of the provision of hospital services, polyclinics, hall treatment, maternity hospital, and specialist hospital. It has three geographic segments: RSU Royal Prima, RS Royal Prima Jambi, and Rumah Sakit Marelan. The company generates the majority of its revenue from RSU Royal Prima segment. The company generates revenue from Drugs and medical supplies, doctors' and nurses' fees, Hospital facilities, Room services, and Others.
67GF Score

Get the complete analysis for ISX:PRIM

6-Month Price Index is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp117.00
Price
Rp78.06
GF Value